Copyright Reports & Markets. All rights reserved.

Global Rabies Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Rabies Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Rabies Treatment Market Size Growth Rate by Product
      • 1.4.2 Cell culture vaccines (CCVs)
      • 1.4.3 Rabies immunoglobulin (RIGs)
      • 1.4.4 Nerve tissue vaccines (NTVs)
    • 1.5 Market by End User
      • 1.5.1 Global Rabies Treatment Market Size Growth Rate by End User
      • 1.5.2 Pre-exposure prophylaxis
      • 1.5.3 Post-exposure prophylaxis
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Rabies Treatment Market Size
      • 2.1.1 Global Rabies Treatment Revenue 2014-2025
      • 2.1.2 Global Rabies Treatment Sales 2014-2025
    • 2.2 Rabies Treatment Growth Rate by Regions
      • 2.2.1 Global Rabies Treatment Sales by Regions
      • 2.2.2 Global Rabies Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Rabies Treatment Sales by Manufacturers
      • 3.1.1 Rabies Treatment Sales by Manufacturers
      • 3.1.2 Rabies Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Rabies Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Rabies Treatment Revenue by Manufacturers
      • 3.2.1 Rabies Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Rabies Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Rabies Treatment Price by Manufacturers
    • 3.4 Rabies Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Rabies Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Rabies Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Rabies Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Rabies Treatment Sales by Product
    • 4.2 Global Rabies Treatment Revenue by Product
    • 4.3 Rabies Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Rabies Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Rabies Treatment by Countries
      • 6.1.1 North America Rabies Treatment Sales by Countries
      • 6.1.2 North America Rabies Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Rabies Treatment by Product
    • 6.3 North America Rabies Treatment by End User

    7 Europe

    • 7.1 Europe Rabies Treatment by Countries
      • 7.1.1 Europe Rabies Treatment Sales by Countries
      • 7.1.2 Europe Rabies Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Rabies Treatment by Product
    • 7.3 Europe Rabies Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Rabies Treatment by Countries
      • 8.1.1 Asia Pacific Rabies Treatment Sales by Countries
      • 8.1.2 Asia Pacific Rabies Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Rabies Treatment by Product
    • 8.3 Asia Pacific Rabies Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Rabies Treatment by Countries
      • 9.1.1 Central & South America Rabies Treatment Sales by Countries
      • 9.1.2 Central & South America Rabies Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Rabies Treatment by Product
    • 9.3 Central & South America Rabies Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Rabies Treatment by Countries
      • 10.1.1 Middle East and Africa Rabies Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Rabies Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Rabies Treatment by Product
    • 10.3 Middle East and Africa Rabies Treatment by End User

    11 Company Profiles

    • 11.1 Cadila Healthcare
      • 11.1.1 Cadila Healthcare Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Cadila Healthcare Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Cadila Healthcare Rabies Treatment Products Offered
      • 11.1.5 Cadila Healthcare Recent Development
    • 11.2 GlaxoSmithKline
      • 11.2.1 GlaxoSmithKline Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GlaxoSmithKline Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 GlaxoSmithKline Rabies Treatment Products Offered
      • 11.2.5 GlaxoSmithKline Recent Development
    • 11.3 Merial
      • 11.3.1 Merial Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merial Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merial Rabies Treatment Products Offered
      • 11.3.5 Merial Recent Development
    • 11.4 Sanofi
      • 11.4.1 Sanofi Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sanofi Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sanofi Rabies Treatment Products Offered
      • 11.4.5 Sanofi Recent Development
    • 11.5 Merck
      • 11.5.1 Merck Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Merck Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Merck Rabies Treatment Products Offered
      • 11.5.5 Merck Recent Development
    • 11.6 Pfizer
      • 11.6.1 Pfizer Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Pfizer Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Pfizer Rabies Treatment Products Offered
      • 11.6.5 Pfizer Recent Development
    • 11.7 Bayer
      • 11.7.1 Bayer Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Bayer Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Bayer Rabies Treatment Products Offered
      • 11.7.5 Bayer Recent Development
    • 11.8 AstraZeneca
      • 11.8.1 AstraZeneca Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 AstraZeneca Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 AstraZeneca Rabies Treatment Products Offered
      • 11.8.5 AstraZeneca Recent Development
    • 11.9 Amneal Pharmaceuticals
      • 11.9.1 Amneal Pharmaceuticals Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Amneal Pharmaceuticals Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Amneal Pharmaceuticals Rabies Treatment Products Offered
      • 11.9.5 Amneal Pharmaceuticals Recent Development
    • 11.10 Anergis
      • 11.10.1 Anergis Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Anergis Rabies Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Anergis Rabies Treatment Products Offered
      • 11.10.5 Anergis Recent Development

    12 Future Forecast

    • 12.1 Rabies Treatment Market Forecast by Regions
      • 12.1.1 Global Rabies Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Rabies Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Rabies Treatment Market Forecast by Product
      • 12.2.1 Global Rabies Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Rabies Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Rabies Treatment Market Forecast by End User
    • 12.4 North America Rabies Treatment Forecast
    • 12.5 Europe Rabies Treatment Forecast
    • 12.6 Asia Pacific Rabies Treatment Forecast
    • 12.7 Central & South America Rabies Treatment Forecast
    • 12.8 Middle East and Africa Rabies Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Rabies Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Rabies Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Rabies Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Rabies Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rabies Treatment in these regions.
      This research report categorizes the global Rabies Treatment market by top players/brands, region, type and end user. This report also studies the global Rabies Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Cadila Healthcare
      GlaxoSmithKline
      Merial
      Sanofi
      Merck
      Pfizer
      Bayer
      AstraZeneca
      Amneal Pharmaceuticals
      Anergis

      Market size by Product
      Cell culture vaccines (CCVs)
      Rabies immunoglobulin (RIGs)
      Nerve tissue vaccines (NTVs)
      Market size by End User
      Pre-exposure prophylaxis
      Post-exposure prophylaxis

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Rabies Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Rabies Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Rabies Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Rabies Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Rabies Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Rabies Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now